GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future ...

ShareUK pharmaceutical giant, GSK said it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...

UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...

Shares of the UK-based pharma giant GlaxoSmithKline PLC ($GB:GSK) soared over 6% after the company announced a settlement of ...

The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the ...

Please verify your email address. The Redmagic Nova tablet is now ready to buy in the US with a starting price of $499 for the 12GB RAM and 256GB storage variant. The tablet offers a 10.9-inch 2K ...

The litigation follows the 2020 FDA decision to pull Zantac from the market because of concerns about its active ingredient, ranitidine, which could degrade into NDMA, a probable carcinogen.

ranitidine, could degrade into NDMA, a carcinogen, over time or when exposed to heat. Three lawsuits over Zantac had previously gone to trial, all in Illinois, with two ending in verdicts for the ...

(Reuters) -The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended ... over concerns that its active ingredient, ranitidine, could degrade into NDMA, a ...